About
Vaccines
Areas of Focus
Categories
VaccineSoutheastern U.S.
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
10,375
By Phase
PHASE1: 2PHASE2: 2
By Status
ACTIVE_NOT_RECRUITING: 2RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06967181Lead Sponsor
A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults
PHASE1Active, not recruiting
60 participants
Started: May 14, 2025 · Completed: Nov 30, 2026
NCT06742281Lead Sponsor
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
PHASE2Recruiting
10,016 participants
Started: Dec 5, 2024 · Completed: Jun 30, 2027
NCT05736835Lead Sponsor
A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
PHASE2Active, not recruiting
227 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2028
NCT04954287Lead Sponsor
Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents
PHASE1Completed
72 participants
Started: Aug 6, 2021 · Completed: Jun 10, 2023
Locations (1)
Headquarters
Athens, GA, United States
Map
Loading map...